Does POMALIDOMIDE Cause Hepatic function abnormal? 59 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 59 reports of Hepatic function abnormal have been filed in association with POMALIDOMIDE (Pomalyst). This represents 0.1% of all adverse event reports for POMALIDOMIDE.
59
Reports of Hepatic function abnormal with POMALIDOMIDE
0.1%
of all POMALIDOMIDE reports
12
Deaths
36
Hospitalizations
How Dangerous Is Hepatic function abnormal From POMALIDOMIDE?
Of the 59 reports, 12 (20.3%) resulted in death, 36 (61.0%) required hospitalization, and 15 (25.4%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for POMALIDOMIDE. However, 59 reports have been filed with the FAERS database.
What Other Side Effects Does POMALIDOMIDE Cause?
Plasma cell myeloma (7,023)
Death (6,795)
Fatigue (6,530)
Pneumonia (5,792)
Off label use (3,845)
Diarrhoea (3,351)
White blood cell count decreased (3,328)
Neutropenia (3,029)
Rash (2,715)
Dyspnoea (2,543)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which POMALIDOMIDE Alternatives Have Lower Hepatic function abnormal Risk?
POMALIDOMIDE vs POMALYST
POMALIDOMIDE vs PONATINIB
POMALIDOMIDE vs PONATINIB\PONATINIB
POMALIDOMIDE vs PONESIMOD
POMALIDOMIDE vs PORACTANT ALFA